The CIN pathway is found in 65%–70% of sporadic CRC cases and is characterized by mutations in oncogenes (KRAS) and tumor suppressor genes (APC and TP53), in addition to chromosomal aberrations (18q deletion). Here, APC is linked to colorectal carcinoma.